Top compounds associated with response to MYRIP


Feature Type Standardized
Nominal ANOVA
mRNA XMD8-92 GDSC1000 pan-cancer AAC -0.12 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.02
mRNA carboplatin:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.074 0.02
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.085 0.02
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.071 0.02
mRNA SB-431542 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA ML203 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.077 0.02
mRNA tandutinib CTRPv2 pan-cancer AAC 0.081 0.03
Download CSV